Paspartu Multilingual Operations for Regulated Markets
Let’s talk

Multilingual pharmaceutical documentation for an EU regulatory authority

Pharmaceutical documentation delivered for EU regulatory evaluation across multiple languages. “Paspartu translated a number of 17.500 pages for the Translation Centre for the Bodies of the European Union.”

Multilingual pharmaceutical documentation for an EU regulatory authority

Context

A European regulatory authority responsible for the evaluation and approval of medicinal products required extensive multilingual support for medical and pharmaceutical documentation used in regulatory assessment processes. The engagement involved a large-scale body of highly sensitive content, delivered over time and used to support decisions affecting the circulation of medicines across European markets. The documentation needed to be available consistently across a broad set of EU languages, without loss of accuracy, clarity, or regulatory intent.

The Challenge

The work covered a substantial volume of complex medical and regulatory material, spanning the full lifecycle of medicinal product evaluation. This included documentation used for:

  • Regulatory approvals and refusals
  • Product information and patient-facing materials
  • Clinical and assessment-related documentation
  • Regulatory and legislative references

Key challenges included:

  • Maintaining consistency across interrelated documents
  • Ensuring accurate interpretation across more than ten European languages
  • Supporting material subject to direct regulatory scrutiny
  • Delivering reliably across an extended engagement period

In this context, accuracy was not a target - it was a prerequisite.

Paspartu’s Role

Paspartu supported the authority as a long-term linguistic partner throughout the engagement. Our role focused on:

  • Delivering precise, context-aware translations of medical and pharmaceutical content
  • Ensuring terminology and interpretation consistency across all target languages, including Bulgarian, German, Greek, Spanish, French, Hungarian, Italian, Portuguese, Croatian, Slovenian, and Slovakian
  • Applying structured review and quality controls appropriate for regulatory use
  • Coordinating multilingual delivery through disciplined workflows and experienced teams
  • Supporting revisions and updates as part of an ongoing regulatory process

The work required a clear understanding of how language functions within regulatory decision-making, not simply linguistic accuracy in isolation.

The Outcome

The regulatory authority received multilingual documentation that met its expectations for accuracy, consistency, and reliability across all required languages. Paspartu’s support enabled:

  • Confident handling of complex regulatory documentation
  • Consistent interpretation of medical content across markets
  • Reliable delivery sustained over time
  • A working relationship grounded in accountability and trust

The collaboration required sustained accuracy, coordination, and consistency across languages, delivered over time within a demanding regulatory context.

Paspartu Multilingual Operations for Regulated Markets
Get the full story